Aristotle Capital Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-17,992
Closed -$202K 172
2023
Q3
$202K Sell
17,992
-53
-0.3% -$615 ﹤0.01% 170
2023
Q2
$182K Sell
18,045
-51
-0.3% -$473 ﹤0.01% 170
2023
Q1
$170K Sell
18,096
-725
-4% -$8.55K ﹤0.01% 172
2022
Q4
$230K Sell
18,821
-5,898,680
-100% -$73.5M ﹤0.01% 175
2022
Q3
$73.4M Sell
5,917,501
-23,527,520
-80% -$411M 0.16% 55
2022
Q2
$578M Buy
29,445,021
+30,384
+0.1% +$719K 1.22% 39
2022
Q1
$767M Buy
29,414,637
+203,795
+0.7% +$5.43M 1.4% 38
2021
Q4
$829M Buy
29,210,842
+1,027,512
+4% +$32M 1.4% 37
2021
Q3
$899M Buy
28,183,330
+176,853
+0.6% +$5.93M 1.7% 31
2021
Q2
$972M Buy
28,006,477
+383,942
+1% +$12.7M 1.86% 29
2021
Q1
$813M Buy
27,622,535
+2,421,880
+10% +$74.5M 1.66% 32
2020
Q4
$773M Buy
25,200,655
+1,099,886
+5% +$33.6M 1.92% 26
2020
Q3
$673M Buy
24,100,769
+91,350
+0.4% +$2.32M 2.03% 25
2020
Q2
$515M Buy
24,009,419
+13,116,783
+120% +$290M 1.73% 30
2020
Q1
$244M Buy
+10,892,636
New +$298M 1.03% 37

Other funds holding ELAN

Aristotle Capital Management's ELAN Position: Q4 2023 in Review

Aristotle Capital Management sold out of Elanco Animal Health (ELAN) in Q4 2023, closing a stake of 17,992 shares — an estimated $202K sold.

Aristotle Capital Management first reported a position in ELAN in Q1 2020 and held it in 15 quarters. The position peaked at $972M in Q2 2021. 355 funds tracked by Wall St. Rank hold ELAN as of Q4 2023.

  • Aristotle Capital Management reported no remaining Elanco Animal Health position as of Q4 2023 after selling out during the quarter.
  • Aristotle Capital Management sold 17,992 Elanco Animal Health shares in Q4 2023, an estimated $202K.
  • Aristotle Capital Management first reported a position in Elanco Animal Health in Q1 2020 and held it in 15 quarters.
  • Aristotle Capital Management's Elanco Animal Health position peaked at $972M in Q2 2021.
  • 355 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2023.

Based on Aristotle Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.